Current research on scopoletin is limited to in vitro and preclinical studies, with no human clinical trials available. In vitro studies have demonstrated significant VEGFR2 inhibition and reduced endothelial cell proliferation, though specific IC50 values and concentration ranges vary across studies. Preclinical evidence shows acetylcholinesterase inhibition comparable to standard compounds, but effective dosages and bioavailability in humans remain unknown. The antibacterial effects have been observed in laboratory studies against various bacterial strains, but clinical applications have not been established.
Origin
Scopoletin is a phenolic coumarin (6-methoxy-7-hydroxycoumarin) with molecular formula C₁₀H₈O₄, naturally occurring in numerous medicinal and edible plants. It is biosynthesized via ortho-hydroxylation of feruloyl-CoA or from 4-coumaroyl-CoA through hydroxylation involving cytochrome P450 enzymes, and extracted using solvents like ethanol or chloroform.
Potential benefits
• Anti-angiogenic effects through inhibition of VEGFR2 and suppression of endothelial cell proliferation (in vitro evidence only) • Potential neuroprotective properties via acetylcholinesterase and monoamine oxidase inhibition (preclinical evidence) • Possible antibacterial activity through FtsZ polymerization inhibition (in vitro studies) • May support cardiovascular health by blocking ERK1/2, p38 MAPK, and Akt pathways (cell culture studies) • Plant growth regulation properties suggesting potential metabolic effects (mechanistic evidence only)
How it works
Scopoletin exerts anti-angiogenic effects by specifically inhibiting vascular endothelial growth factor receptor 2 (VEGFR2), which prevents endothelial cell proliferation and new blood vessel formation. The compound demonstrates neuroprotective activity through dual inhibition of acetylcholinesterase and monoamine oxidase enzymes, potentially preserving neurotransmitter levels. Additionally, scopoletin shows antibacterial properties by targeting the FtsZ protein, which is essential for bacterial cell division.
What the research says
No human clinical trials, RCTs, or meta-analyses have been conducted on scopoletin supplementation. All available evidence is limited to preclinical in vitro and animal studies examining mechanisms like VEGFR2 autophosphorylation inhibition and effects on endothelial cells.
Safety and interactions
Safety data for scopoletin supplementation in humans is extremely limited due to lack of clinical trials. As a coumarin derivative, scopoletin may theoretically interact with anticoagulant medications like warfarin, potentially affecting blood clotting mechanisms. The compound's monoamine oxidase inhibitory activity suggests possible interactions with antidepressants, particularly MAO inhibitors and SSRIs. Pregnancy and breastfeeding safety has not been established, and the compound should be avoided during these periods due to insufficient safety data.
Suggested use
No clinically studied dosage ranges are available as human trials have not been conducted. Pharmacokinetic studies note low bioavailability and rapid absorption, but specific dosages or standardization levels have not been established. Consult a healthcare provider before starting any new supplement.
Frequently asked questions
What foods contain scopoletin naturally?
Scopoletin is found naturally in sweet potatoes, morinda citrifolia (noni fruit), coffee beans, and various medicinal plants like Artemisia species. The concentration varies significantly depending on the plant source and extraction method used.
How does scopoletin compare to other coumarins?
Unlike warfarin which has strong anticoagulant effects, scopoletin shows minimal blood-thinning activity but stronger anti-angiogenic properties. Scopoletin also demonstrates unique neuroprotective effects not commonly seen in other coumarin compounds like umbelliferone.
Can scopoletin help with cancer treatment?
In vitro studies show scopoletin can inhibit tumor blood vessel formation through VEGFR2 blocking, but no human cancer trials exist. The anti-angiogenic effects are promising but require extensive clinical research before any therapeutic applications can be considered.
What is the effective dosage of scopoletin?
No established human dosage exists for scopoletin due to lack of clinical trials. In vitro studies use concentrations ranging from 10-100 μM, but these laboratory doses cannot be directly translated to human supplementation recommendations.
Does scopoletin have any proven brain benefits?
Preclinical studies show scopoletin inhibits acetylcholinesterase and monoamine oxidase enzymes, which could theoretically support brain function. However, no human studies have confirmed actual cognitive benefits or established whether scopoletin crosses the blood-brain barrier effectively.
Is scopoletin safe to take with blood thinners or anticoagulant medications?
Scopoletin's coumarin structure raises theoretical concerns about interaction with warfarin and other anticoagulants, though human studies are lacking. If you take blood thinners, consult your healthcare provider before supplementing with scopoletin, as coumarin compounds can potentially potentiate anticoagulant effects. Current evidence is limited to preclinical research, making clinical safety data unavailable.
References
This article is educational and is not medical advice. Statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before use.
